Copyright Reports & Markets. All rights reserved.

Global and China Biotherapeutics Cell Line Development Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Transfection & Selection
    • 1.2.3 Single Cell Cloning
  • 1.3 Market by Application
    • 1.3.1 Global Biotherapeutics Cell Line Development Market Share by Application: 2020 VS 2026
    • 1.3.2 In-house
    • 1.3.3 Outsource
    • 1.3.4 Hybrid
    • 1.3.5 Do-It-Yourself (DIY)
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biotherapeutics Cell Line Development Market Perspective (2015-2026)
  • 2.2 Global Biotherapeutics Cell Line Development Growth Trends by Regions
    • 2.2.1 Biotherapeutics Cell Line Development Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biotherapeutics Cell Line Development Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biotherapeutics Cell Line Development Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biotherapeutics Cell Line Development Players by Market Size
    • 3.1.1 Global Top Biotherapeutics Cell Line Development Players by Revenue (2015-2020)
    • 3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Players (2015-2020)
  • 3.2 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biotherapeutics Cell Line Development Revenue
  • 3.4 Global Biotherapeutics Cell Line Development Market Concentration Ratio
    • 3.4.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2019
  • 3.5 Key Players Biotherapeutics Cell Line Development Area Served
  • 3.6 Key Players Biotherapeutics Cell Line Development Product Solution and Service
  • 3.7 Date of Enter into Biotherapeutics Cell Line Development Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biotherapeutics Cell Line Development Breakdown Data by Type (2015-2026)

  • 4.1 Global Biotherapeutics Cell Line Development Historic Market Size by Type (2015-2020)
  • 4.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2021-2026)

5 Biotherapeutics Cell Line Development Breakdown Data by Application (2015-2026)

  • 5.1 Global Biotherapeutics Cell Line Development Historic Market Size by Application (2015-2020)
  • 5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biotherapeutics Cell Line Development Market Size (2015-2026)
  • 6.2 North America Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 6.3 North America Biotherapeutics Cell Line Development Market Size by Application (2015-2020)
  • 6.4 North America Biotherapeutics Cell Line Development Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Biotherapeutics Cell Line Development Market Size (2015-2026)
  • 7.2 Europe Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 7.3 Europe Biotherapeutics Cell Line Development Market Size by Application (2015-2020)
  • 7.4 Europe Biotherapeutics Cell Line Development Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Biotherapeutics Cell Line Development Market Size (2015-2026)
  • 8.2 China Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 8.3 China Biotherapeutics Cell Line Development Market Size by Application (2015-2020)
  • 8.4 China Biotherapeutics Cell Line Development Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Biotherapeutics Cell Line Development Market Size (2015-2026)
  • 9.2 Japan Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 9.3 Japan Biotherapeutics Cell Line Development Market Size by Application (2015-2020)
  • 9.4 Japan Biotherapeutics Cell Line Development Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Biotherapeutics Cell Line Development Market Size (2015-2026)
  • 10.2 Southeast Asia Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Biotherapeutics Cell Line Development Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Biotherapeutics Cell Line Development Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Becton Dickinson & Company
    • 11.1.1 Becton Dickinson & Company Company Details
    • 11.1.2 Becton Dickinson & Company Business Overview
    • 11.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
    • 11.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2015-2020))
    • 11.1.5 Becton Dickinson & Company Recent Development
  • 11.2 Beckman Coulter
    • 11.2.1 Beckman Coulter Company Details
    • 11.2.2 Beckman Coulter Business Overview
    • 11.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
    • 11.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.2.5 Beckman Coulter Recent Development
  • 11.3 Boehringer Ingelheim Group
    • 11.3.1 Boehringer Ingelheim Group Company Details
    • 11.3.2 Boehringer Ingelheim Group Business Overview
    • 11.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
    • 11.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.3.5 Boehringer Ingelheim Group Recent Development
  • 11.4 Catalent Inc.
    • 11.4.1 Catalent Inc. Company Details
    • 11.4.2 Catalent Inc. Business Overview
    • 11.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
    • 11.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.4.5 Catalent Inc. Recent Development
  • 11.5 CMC Biologics A/S
    • 11.5.1 CMC Biologics A/S Company Details
    • 11.5.2 CMC Biologics A/S Business Overview
    • 11.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
    • 11.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.5.5 CMC Biologics A/S Recent Development
  • 11.6 Lonza Group Ltd.
    • 11.6.1 Lonza Group Ltd. Company Details
    • 11.6.2 Lonza Group Ltd. Business Overview
    • 11.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
    • 11.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.6.5 Lonza Group Ltd. Recent Development
  • 11.7 EMD Millipore
    • 11.7.1 EMD Millipore Company Details
    • 11.7.2 EMD Millipore Business Overview
    • 11.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
    • 11.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.7.5 EMD Millipore Recent Development
  • 11.8 Partec (Sysmex Corporation)
    • 11.8.1 Partec (Sysmex Corporation) Company Details
    • 11.8.2 Partec (Sysmex Corporation) Business Overview
    • 11.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
    • 11.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.8.5 Partec (Sysmex Corporation) Recent Development
  • 11.9 ProBioGen AG
    • 11.9.1 ProBioGen AG Company Details
    • 11.9.2 ProBioGen AG Business Overview
    • 11.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
    • 11.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.9.5 ProBioGen AG Recent Development
  • 11.10 Selexis SA
    • 11.10.1 Selexis SA Company Details
    • 11.10.2 Selexis SA Business Overview
    • 11.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
    • 11.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 11.10.5 Selexis SA Recent Development
  • 11.11 Sigma-Aldrich Co. LLC.
    • 10.11.1 Sigma-Aldrich Co. LLC. Company Details
    • 10.11.2 Sigma-Aldrich Co. LLC. Business Overview
    • 10.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
    • 10.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 10.11.5 Sigma-Aldrich Co. LLC. Recent Development
  • 11.12 Sony Biotechnology Inc.
    • 10.12.1 Sony Biotechnology Inc. Company Details
    • 10.12.2 Sony Biotechnology Inc. Business Overview
    • 10.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
    • 10.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 10.12.5 Sony Biotechnology Inc. Recent Development
  • 11.13 Thermo Fisher Scientific Inc.
    • 10.13.1 Thermo Fisher Scientific Inc. Company Details
    • 10.13.2 Thermo Fisher Scientific Inc. Business Overview
    • 10.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
    • 10.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 10.13.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Biotherapeutics Cell Line Development Scope and Market Size
    Biotherapeutics Cell Line Development market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biotherapeutics Cell Line Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Transfection & Selection
    Single Cell Cloning

    Market segment by Application, split into
    In-house
    Outsource
    Hybrid
    Do-It-Yourself (DIY)

    Based on regional and country-level analysis, the Biotherapeutics Cell Line Development market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Biotherapeutics Cell Line Development market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Becton Dickinson & Company
    Beckman Coulter
    Boehringer Ingelheim Group
    Catalent Inc.
    CMC Biologics A/S
    Lonza Group Ltd.
    EMD Millipore
    Partec (Sysmex Corporation)
    ProBioGen AG
    Selexis SA
    Sigma-Aldrich Co. LLC.
    Sony Biotechnology Inc.
    Thermo Fisher Scientific Inc.

    Buy now